Manage settings
MENU
About this site
In het Nederlands
Home
Researchers
Projects
Organisations
Publications
Infrastructure
Contact
Research Explorer
Your browser does not support JavaScript or JavaScript is not enabled. Without JavaScript some functions of this webapplication may be disabled or cause error messages. To enable JavaScript, please consult the manual of your browser or contact your system administrator.
Researcher
Triana Lobatón Ortega
Profile
Projects
Publications
Activities
Awards & Distinctions
99
Results
2025
Gastrointestinal disease in common variable immunodeficiency disorder (CVID) : histological patterns, diagnostic clues and pitfalls for the pathologist and gastroenterologist
Lars Velthof
Jeroen Geldof
Marie Truyens
Jo Van Dorpe
Liesbeth Ferdinande
Ciel De Vriendt
Tessa Kerre
Filomeen Haerynck
Triana Lobatón Ortega
Anne Hoorens
A1
Journal Article
in
JOURNAL OF CLINICAL MEDICINE
2025
2024
Age-related patterns in biological therapy use and surgery among patients with IBD : insights from the Belgian PANTHER cohort
Jade Celis
Marie Truyens
S Verstockt
Elien Glorieus
M De Wolf
M Lenfant
M Barbaraci
J Sabino
M Ferrante
Jeroen Geldof
et al.
C3
Conference
2024
Case report and review of literature : IgG4-gastroduodenitis in upper GI Crohn’s disease : two separate entities or just a marker of disease severity?
Valérie Desmedt
Jeroen Geldof
Anne Hoorens
Triana Lobatón Ortega
A1
Journal Article
in
FRONTIERS IN MEDICINE
2024
Did we overreact? Insights on COVID-19 disease and vaccination in a large cohort of immune-mediated inflammatory disease patients during sequential phases of the pandemic (the BELCOMID study)
Jeroen Geldof
Marie Truyens
João Sabino
Marc Ferrante
Jo Lambert
Hilde Lapeere
Tom Hillary
An Van Laethem
Kurt de Vlam
Patrick Verschueren
et al.
A1
Journal Article
in
VACCINES
2024
Disease outcomes and patient’s perspectives after switching biologics from intravenous to subcutaneous administration : a real-world experience in a tertiary IBD-unit
G Dewitte
S Akhayad
Marie Truyens
Jeroen Geldof
Triana Lobatón Ortega
C3
Conference
2024
MIP4IBD: An Easy and Rapid Genotyping-by-Sequencing Assay for the Inflammatory Bowel Diseases Risk Loci.
Sare Verstockt
Laurens Hannes
Deborah Sarah Jans
Stephanie Deman
Erika Souche
Ilse van der Werf
Liv Vandermeulen
Triana Lobatón Ortega
Debby Laukens
Bram Verstockt
et al.
U
Journal Article
in
Inflammatory bowel diseases
2024
New onset inflammatory bowel disease after initiation of anti-IL-17a treatment : a case series
Jeroen Geldof
Marie Truyens
B. Strubbe
S. Claeys
Goedele Dewitte
Elien Glorieus
Anne Hoorens
Triana Lobatón Ortega
A1
Journal Article
in
ACTA GASTRO-ENTEROLOGICA BELGICA
2024
Post-discharge outcomes of elderly patients hospitalized for inflammatory bowel disease flare complicated by Clostridioides difficile infection
Idan Goren
Ortal Fallek Boldes
Tomer Boldes
Oleg Knyazev
Anna Kagramanova
Jimmy K Limdi
Eleanor Liu
Karishma Sethi-Arora
Tom Holvoet
Piotr Eder
et al.
A1
Journal Article
in
JOURNAL OF CROHNS & COLITIS
2024
Prophylactic versus endoscopy-driven treatment of Crohn’s postoperative recurrence : a retrospective, multicentric, European study [PORCSE Study]
Jeroen Geldof
Marie Truyens
Michiel Hanssens
Emily Van Gucht
Tom Holvoet
Ainara Elorza
Vincent Bouillon
Sónia Barros
Viviana Martins
Konstantinos Argyriou
et al.
A1
Journal Article
in
JOURNAL OF CROHNS & COLITIS
2024
Respiratory failure in a tofacitinib treated patient with ulcerative colitis
Cedric Bosteels
Marie Truyens
Yannick Vande Weygaerde
Thomas Malfait
Sasha Libbrecht
Liesbeth Ferdinande
Jeroen Geldof
Triana Lobatón Ortega
A1
Journal Article
in
ACTA GASTRO-ENTEROLOGICA BELGICA
2024
Safety and effectiveness of vedolizumab and ustekinumab in elderly patients with inflammatory bowel disease : a real-life multicentric cohort study
Tom Holvoet
Marie Truyens
Cara De Galan
Harald Peeters
Francisco Mesonero Gismero
Ainara Elorza
Paola Torres
Liv Vandermeulen
Aranzazu Jauregui-Amezaga
Rocio Ferreiro-Iglesias
et al.
A1
Journal Article
in
JOURNAL OF CLINICAL MEDICINE
2024
Successful treatment of ulcerative colitis with anakinra : a case report
Marie Truyens
Levi Hoste
Jeroen Geldof
Anne Hoorens
Filomeen Haerynck
Diana Huis in 't Veld
Triana Lobatón Ortega
A1
Journal Article
in
ACTA GASTRO-ENTEROLOGICA BELGICA
2024
The comparative effectiveness and safety of different biologics in young (<60 years) versus elderly (≥60 years) patients with IBD : results from a real-world experience at a Belgian tertiary centre
Liesbeth Deroo
Marie Truyens
Jeroen Geldof
Soumaya Akhayad
G Dewitte
Elien Glorieus
Triana Lobatón Ortega
C3
Conference
2024
Unraveling the fatigue puzzle : insights into the pathogenesis and management of IBD-related fatigue including the role of the gut-brain axis
Marie Truyens
Hannah Lernout
Martine De Vos
Debby Laukens
Triana Lobatón Ortega
A1
Journal Article
in
FRONTIERS IN MEDICINE
2024
2023
A comprehensive metabolite fingerprint of fibrostenosis in patients with Crohn’s disease
Simon Bos
Triana Lobatón Ortega
Martine De Vos
Sophie Van Welden
Vera Plekhova
Ellen De Paepe
Lynn Vanhaecke
Debby Laukens
A1
Journal Article
in
SCIENTIFIC REPORTS
2023
Anti-CD74 IgA antibodies show diagnostic potential for axial spondyloarthritis but are not associated with microscopic gut inflammation
Ann-Sophie De Craemer
Torsten Witte
Triana Lobatón Ortega
Anne Hoorens
Martine De Vos
Claude Cuvelier
Sebastiaan J. Vastert
Xenofon Baraliakos
Filip Van den Bosch
Dirk Elewaut
A1
Journal Article
in
RHEUMATOLOGY
2023
Autoimmune pancreatitis in patients with inflammatory bowel disease : a real-world multicentre collaborative ECCO CONFER study
Piotr Eder
Bram Verstock
Emma Culver
Gabriele Dragoni
Lea Isabell Kredel
Joanna Wypych
Ana Garcia Garcia de Paredes
Magdalena Kaniewska
Haim Leibovitzh
Triana Lobatón Ortega
et al.
A1
Journal Article
in
JOURNAL OF CROHNS & COLITIS
2023
Comparison of short- and long-term effectiveness between anti-TNF and ustekinumab after vedolizumab failure as first-line therapy in Crohn’s disease : a multi-center retrospective cohort study
Ahmad Albshesh
Lian Bannon
Tali Sharar Fischler
Marie Truyens
Stephan R. Vavricka
Katja Tepes
Daniela Pugliese
Edoardo V. Savarino
Eran Zittan
David Drobne
et al.
A1
Journal Article
in
JOURNAL OF CLINICAL MEDICINE
2023
Distinct immune modulatory roles of regulatory T cells in gut versus joint inflammation in TNF-driven spondyloarthritis
Koen Venken
Matthias Jarlborg
Tine Decruy
Céline Mortier
Carolien Vlieghe
Elisabeth Gilis
Ann-Sophie De Craemer
Julie Coudenys
Isabelle Cambré
Devan Fleury
et al.
A1
Journal Article
in
ANNALS OF THE RHEUMATIC DISEASES
2023
Editorial : LAG‐3‐depleting monoclonal antibody : a potential treatment for patients with ulcerative colitis?
Triana Lobatón Ortega
Marie Truyens
Editorial material
2023
Gut inflammation in axial spondyloarthritis patients is characterized by a marked type 17 skewed mucosal innate‐like T cell signature
Céline Mortier
Katrien Quintelier
Ann-Sophie De Craemer
Thomas Renson
Liselotte Deroo
Emilie Dumas
Eveline Verheugen
Julie Coudenys
Tine Decruy
Zuzanna Łukasik
et al.
A1
Journal Article
in
ARTHRITIS & RHEUMATOLOGY
2023
Position statement on the management of the immune checkpoint inhibitor-induced colitis via multidisciplinary modified Delphi consensus
Valérie Desmedt
Aranzazu Jauregui-Amezaga
Liselotte Fierens
Sandrine Aspeslagh
Jeroen Dekervel
Els Wauters
Marc Peeters
Joao Sabino
Lara Crape
Michael Somers
et al.
A1
Journal Article
in
EUROPEAN JOURNAL OF CANCER
2023
SARS-CoV-2 infection and COVID19 vaccination across eight immune-mediated inflammatory disorders : a prospective, real-life Belgian cohort study - the BELCOMID study
Jeroen Geldof
Marie Truyens
João Sabino
Marc Ferrante
Jo Lambert
Hilde Lapeere
Tom Hillary
An Van Laethem
Kurt de Vlam
Patrick Verschueren
et al.
A1
Journal Article
in
FRONTIERS IN IMMUNOLOGY
2023
Studying the pathogenesis of persistent fatigue in inflammatory bowel diseases
Marie Truyens
Debby Laukens
Triana Lobatón Ortega
Roosmarijn Vandenbroucke
Dissertation
2023
The PROPER study : a 48-week, pan-European, real-world study of biosimilar SB5 following transition from reference adalimumab in patients with immune-mediated inflammatory disease
Ulf Mueller-Ladner
Axel Dignass
Karl Gaffney
Deepak Jadon
Marco Matucci-Cerinic
Triana Lobatón Ortega
Philippe Carron
Javier P. Gisbert
Ira Pande
Maximilian Utzinger
et al.
A1
Journal Article
in
BIODRUGS
2023
2022
A randomized placebo controlled clinical trial with 5-hydroxytryptophan in patients with quiescent Inflammatory Bowel Disease and fatigue (Trp-IBD)
Marie Truyens
Triana Lobatón Ortega
Anneleen Peeters
Marc Ferrante
Séverine Vermeire
Peter Bossuyt
Lieven Pouillon
Pieter Dewint
Anneline Cremer
Harald Peeters
et al.
C3
Conference
2022
Effect of 5-hydroxytryptophan on fatigue in quiescent inflammatory bowel disease : a randomized controlled trial
Marie Truyens
Triana Lobatón Ortega
Marc Ferrante
Peter Bossuyt
Séverine Vermeire
Lieven Pouillon
Pieter Dewint
Anneline Cremer
Harald Peeters
Guy Lambrecht
et al.
A1
Journal Article
in
GASTROENTEROLOGY
2022
Endoscopic postoperative recurrence in Crohn's disease after curative ileocecal resection with early prophylaxis by anti-TNF, vedolizumab or ustekinumab : a real-world multicenter European study
Henit Yanai
Anna Kagramanova
Oleg Knyazev
João Sabino
Shana Haenen
Gerassimos J Mantzaris
Katerina Mountaki
Alessandro Armuzzi
Daniela Pugliese
Federica Furfaro
et al.
A1
Journal Article
in
JOURNAL OF CROHNS & COLITIS
2022
Gastroenteropancreatic neuroendocrine neoplasms in patients with inflammatory bowel fisease : an ECCO CONFER multicentre case series
Stefano Festa
Giulia Zerboni
Lauranne A A P Derikx
Davide Giuseppe Ribaldone
Gabriele Dragoni
Christianne Buskens
Els Nieveen van Dijkum
Daniela Pugliese
Francesco Panzuto
Iwona Krela-Kaźmierczak
et al.
A1
Journal Article
in
JOURNAL OF CROHNS & COLITIS
2022
Infliximab re-challenge : could it be an option in refractory IBD patients?
Marie Truyens
Eva Pijoan Comas
Elien Glorieus
Jeroen Geldof
Triana Lobatón Ortega
C3
Conference
2022
Role of integrin expression in the prediction of response to vedolizumab : a prospective real‐life multicentre cohort study
Cara De Galan
Bryan Gonzales
Sophie Van Welden
Simon Tavernier
Triana Lobatón Ortega
Wouter Van Moerkercke
Beatrijs Strubbe
Harald Peeters
Elisabeth Macken
Martine De Vos
et al.
A1
Journal Article
in
CLINICAL AND TRANSLATIONAL MEDICINE
2022
The impact of vedolizumab and ustekinumab on articular extra-intestinal manifestations in inflammatory bowel disease patients : a real-life multicentre cohort study
Cara De Galan
Marie Truyens
Harald Peeters
Francisco Mesonero Gismero
Ainara Elorza
Paola Torres
Liv Vandermeulen
Aranzazu Jauregui Amezaga
Rocio Ferreiro- Iglesias
Tom Holvoet
et al.
A1
Journal Article
in
JOURNAL OF CROHNS & COLITIS
2022
2021
A discriminative metabolic profile in the sera of Crohn's disease patients with fibrostenosis
Simon Bos
Martine De Vos
Pieter Hindryckx
Triana Lobatón Ortega
Lynn Vanhaecke
Debby Laukens
C3
Conference
2021
Can serum metabolomics discriminate the Crohn’s disease fibrostenotic phenotype?
Simon Bos
Sophie Van Welden
Martine De Vos
Pieter Hindryckx
Triana Lobatón Ortega
Lynn Vanhaecke
Debby Laukens
C3
Conference
2021
Early prediction of response to vedolizumab in patients with active inflammatory bowel disease : a prospective real-life multicentre cohort study
Cara De Galan
Gerard Bryan Gonzales
Sophie Van Welden
Simon Tavernier
Triana Lobatón Ortega
Wouter Van Moerkercke
Beatrijs Strubbe
Harald Peeters
Elisabeth Macken
Martine De Vos
et al.
C3
Conference
2021
Effectiveness of third-class biologic treatment in Crohn’s disease : a multi-center retrospective cohort study
Ahmad Albshesh
Joshua Taylor
Edoardo V. Savarino
Marie Truyens
Alessandro Armuzzi
Davide G. Ribaldone
Ariella Bar-Gil Shitrit
Morine Fibelman
Pauliina Molander
Claire Liefferinckx
et al.
A1
Journal Article
in
JOURNAL OF CLINICAL MEDICINE
2021
Efficacy of anti-TNF dosing interval lengthening in adolescents and young adults with inflammatory bowel disease in sustained remission (FREE-study) : protocol for a partially randomised patient preference trial
Marleen Bouhuys
Willem S Lexmond
Gerard Dijkstra
Triana Lobatón Ortega
Edouard Louis
Stephanie Van Biervliet
Henk Groen
Jordi Guardiola
Patrick van Rheenen
A1
Journal Article
in
BMJ OPEN
2021
First results of the BELCOMID study : Belgian cohort study of COVID-19 in Immune Mediated Inflammatory Diseases (IMID)
Jeroen Geldof
Marie Truyens
J Sabino
M Ferrante
Jo Lambert
Hilde Lapeere
T Hillary
A Van Laethem
K De Vlam
P Verschueren
et al.
C3
Conference
2021
Gastroenteropancreatic neuroendocrine neoplasms in patients with inflammatory bowel disease : an ECCO CONFER multicentre case series
S Festa
G Zerboni
L Derikx
D G Ribaldone
G Dragoni
C J Buskens
E Nieveen van Dijkum
D Pugliese
F Panzuto
I Krela-Kaźmierczak
et al.
C3
Conference
2021
Long-term environmental hypoxia does not impact experimental Crohn's like ileitis
Cara De Galan
Sophie Van Welden
Triana Lobatón Ortega
Pieter Hindryckx
Martine De Vos
Debby Laukens
C3
Conference
2021
Optimal management of acute severe ulcerative colitis (ASUC) : challenges and solutions
Tom Holvoet
Triana Lobatón Ortega
Pieter Hindryckx
A2
Journal Article
in
CLINICAL AND EXPERIMENTAL GASTROENTEROLOGY
2021
Patient perspectives on the role of the IBD nurse and telemedicine during COVID-19 pandemic : results from a Belgian tertiary IBD unit
Goedele Dewitte
Jeroen Geldof
Marie Truyens
Triana Lobatón Ortega
C3
Conference
2021
Safety of vedolizumab and ustekinumab in elderly IBD patients : a real-life multicentric cohort study
Cara De Galan
Marie Truyens
Harald Peeters
Francisco Mesonero Gismero
Ainara Elorza
Paola Torres
Liv Vandermeulen
Aranzazu Jauregui Amezaga
Rocio Ferreiro-Iglesias
Tom Holvoet
et al.
C3
Conference
2021
The impact of vedolizumab and ustekinumab on arthropathy and arthralgia in IBD patients : a real-life multicentric cohort study
Marie Truyens
Cara De Galan
H Peeters
F Mesonero Gismero
A Elorza
P Torres
L Vandermeulen
A Jauregui Amezaga
R Ferreiro-Iglesias
T Holvoet
et al.
C3
Conference
2021
2020
Effectiveness of dose escalation in Crohn's disease patients with insufficient response to standard-dose subcutaneous ustekinumab maintenance therapy : a multicentre international cohort study
U. Kopylov
J. Hanzel
C. Liefferinckx
D. De Marco
N. Imperatore
N. Plevris
I. Baston-Rey
R. Harris
Marie Truyens
V. Domislovic
et al.
C3
Conference
2020
Effectiveness of ustekinumab dose escalation in Crohn's disease patients with insufficient response to standard-dose subcutaneous maintenance therapy
Uri Kopylov
Jurij Hanzel
Claire Liefferinckx
Davide De Marco
Nicola Imperatore
Nikolas Plevris
Iria Baston-Rey
Richard J. Harris
Marie Truyens
Viktor Domislovic
et al.
A1
Journal Article
in
ALIMENTARY PHARMACOLOGY & THERAPEUTICS
2020
Effectiveness of ustekinumab in refractory Crohn's disease : a real-life experience in a tertiary referral centre
Marie Truyens
Jeroen Geldof
G. Dewitte
ELIEN GLORIEUS
Pieter Hindryckx
Triana Lobatón Ortega
C3
Conference
2020
Integrin expression changes on the T cells subsets influence the response to vedolizumab in inflammatory bowel disease patients
Cara De Galan
Sophie Van Welden
Simon Bos
Simon Tavernier
Triana Lobatón Ortega
Bryan Gonzales
Wouter Van Moerkercke
Beatrijs Strubbe
Harald Peeters
Elisabeth Macken
et al.
C3
Conference
2020
New onset spondyloarthropathy in vedolizumab treated IBD patients
A. M. Tetley
Triana Lobatón Ortega
Marie Truyens
K. H. Katsanos
K. H. N. de Boer
A. Pattinson
T. Molnar
R. Filip
G. Michalopoulos
S. Sebastian
C3
Conference
2020
Safety and efficacy of combining biological therapies together or with small molecules in patients with inflammatory bowel disease : a retrospective multicentre national observational case series study
L. Goessens
J. F. Colombel
A. Outtier
M. Ferrante
Marie Truyens
Triana Lobatón Ortega
F. Baert
P. Bossuyt
A. Cremer
E. Macken
et al.
C3
Conference
2020
The effect of age on infliximab pharmacokinetics in patients with inflammatory bowel disease
W. Kantasiripitak
B. Verstockt
Triana Lobatón Ortega
D. Thomas
A. Gils
S. Vermeire
M. Ferrante
E. Dreesen
C3
Conference
2020
The impact of vedolizumab on extra-intestinal manifestations in inflammatory bowel disease patients : a real-life experience of a single-centre cohort
Marie Truyens
Jeroen Geldof
G. Dewitte
Elien Glorieus
Gaëlle Varkas
Dirk Elewaut
Triana Lobatón Ortega
C3
Conference
2020
Tofacitinib induces clinical and endoscopic remission in biologic refractory ulcerative colitis patients : a real-world Belgium cohort study
Anneline Cremer
Triana Lobatón Ortega
Sophie Vieujean
Peter Bossuyt
Jean-Francois Rahier
Filip J. Baert
Olivier Dewit
Elisabeth Macken
Michael Somers
Anne Vijverman
et al.
C3
Conference
2020
eTofacitinib induces clinical and endoscopic remission in biologic refractory ulcerative colitis patients : a real-world Belgian cohort study
A. Cremer
Triana Lobatón Ortega
S. Vieujan
P. Bossuyt
J. F. Rahier
F. Baert
O. Dewit
M. Somers
E. Macken
A. Vijverman
et al.
C3
Conference
2020
2019
Effectiveness of third-class biologic treatment in Crohn's disease : a multi-center retrospective cohort study
Ahmad Albshesh
Joshua Taylor
Carla Marinelli
Marie Truyens
Alessandro Armuzzi
Davide Ribaldone
Ariella Bar-Gil Shitrit
Morine Fibelman
Pauliina Molander
Claire Liefferinckx
et al.
C3
Conference
2019
Efficacy of Ustekinumab intensification and re-induction in Crohn’s disease patients with insufficient or loss of response
Marie Truyens
Marleen Goossens
Elien Glorieus
Jeroen Geldof
Pieter Hindryckx
Triana Lobatón Ortega
C3
Conference
2019
Ileal but not colonic inflammation is linked to fatty lesions on MRI of the sacroiliac joints in spondyloarthritis patients
Ann-Sophie De Craemer
Manouk de Hooge
Thomas Renson
Liselotte Deroo
Triana Lobatón Ortega
Anne Hoorens
Philippe Carron
Filip Van den Bosch
Dirk Elewaut
[missing] Be-Giant consortium
C3
Conference
2019
Integrin expression changes on the T cell subsets influence the response to vedolizumab in inflammatory bowel disease patients
Cara De Galan
Sophie Van Welden
Simon Bos
Simon Tavernier
Triana Lobatón Ortega
Bryan Gonzales
Wouter Van Moerkercke
Beatrijs Strubbe
Harald Peeters
Elisabeth Macken
et al.
C3
Conference
2019
Nivolumab-induced immune-mediated colitis : an ulcerative colitis look-alikereport of new cases and review of the literature
Fiorella Canete
Miriam Manosa
Triana Lobatón Ortega
Francisco Mesonero
Iago Rodriguez-Lago
Eduard Cabre
Jose L. Cabriada
Antonio Lopez-Sanroman
Eugeni Domenech
A1
Journal Article
in
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
2019
Relevant infections in inflammatory bowel disease, and their relationship with immunosuppressive therapy and their effects on disease mortality
Yamile Zabana
Lorena Rodriguez
Triana Lobatón Ortega
Jordi Gordillo
Antonia Montserrat
Raquel Mena
Belen Beltran
Marina Dotti
Olga Benitez
Jordi Guardiola
et al.
A1
Journal Article
in
JOURNAL OF CROHNS & COLITIS
2019
Retrospective study of the effectiveness and safety of Ustekinumab in refractory Crohn's Disease
Marie Truyens
Marleen Goossens
Elien Glorieus
Jeroen Geldof
Pieter Hindryckx
Triana Lobatón Ortega
C3
Conference
2019
Young GI angle : should I go abroad?
Triana Lobatón Ortega
Alessandro Armuzzi
Other
2019
2018
Editorial : infliximab trough levels and histological healing in ulcerative colitis-a step towards personalised biologic therapy
Triana Lobatón Ortega
M. De Vos
Editorial material
2018
Long-term safety of in utero exposure to anti-TNF alpha drugs for the treatment of inflammatory bowel disease : results from the Multicenter European TEDDY Study
M. Chaparro
A. Verreth
Triana Lobatón Ortega
E. Gravito-Soares
M. Julsgaard
E. Savarino
F. Magro
I. Avni Biron
P. Lopez-Serrano
M. J. Casanova
et al.
A1
Journal Article
in
AMERICAN JOURNAL OF GASTROENTEROLOGY
2018
New methylation biomarker panel for early diagnosis of dysplasia or cancer in high-risk inflammatory bowel disease patients
Daniel Azuara
Susanna Ausso
Francisco Rodriguez-Moranta
Jordi Guardiola
Xavier Sanjuan
Triana Lobatón Ortega
Jaume Boadas
Marta Piqueras
David Monfort
Elisabet Guino
et al.
A1
Journal Article
in
INFLAMMATORY BOWEL DISEASES
2018
Primoinfección por citomegalovirus en enfermedad inflamatoria intestinal
Paola Torres
Triana Lobatón Ortega
Fiorella Canete
Ariadna Clos
Miriam Manosa
Eduard Cabre
Eugeni Domenech
Editorial material
2018
Prognostic value of histological activity in patients with ulcerative colitis in deep remission : a prospective multicenter study
Triana Lobatón Ortega
Talat Bessissow
Alexandra Ruiz-Cerulla
Gert De Hertogh
Raf Bisschops
Jordi Guardiola
Gert Van Assche
Severine Vermeire
Marc Ferrante
A1
Journal Article
in
UNITED EUROPEAN GASTROENTEROLOGY JOURNAL
2018
Recomendaciones del Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa (GETECCU) sobre la utilidad de la determinación de calprotectina fecal en la enfermedad inflamatoria intestinal
Jordi Guardiola
Triana Lobatón Ortega
Elena Cerrillo
Rocio Ferreiro-Iglesias
Javier P. Gisbert
Eugeni Domenech
Maria Chaparro
Maria Esteve
Francisco Rodriguez-Moranta
A1
Journal Article
in
GASTROENTEROLOGIA Y HEPATOLOGIA
2018
Uncertain usefulness of infliximab trough levels for therapeutic decision-making in inflammatory bowel disease patients on infliximab maintenance therapy
F. Canete
Triana Lobatón Ortega
E. Cabre
M. Manosa
A. Teniente
A. Clos
P. Torres
G. Valldosera
E. Martinez-Caceres
E. Domenech
C3
Conference
2018
2017
A simplified Geboes score for ulcerative colitis
Aranzazu Jauregui-Amezaga
Auke Geerits
Yannick Das
Bart Lemmens
Xavier Sagaert
Talat Bessissow
Triana Lobatón Ortega
Marc Ferrante
Gert Van Assche
Raf Bisschops
et al.
A1
Journal Article
in
JOURNAL OF CROHNS & COLITIS
2017
Acute histological inflammatory activity is associated with clinical relapse in patients with ulcerative colitis in clinical and endoscopic remission
Margalida Calafat
Triana Lobatón Ortega
Alba Hernandez-Gallego
Miriam Manosa
Paola Torres
Fiorella Canete
Eduard Cabre
Isabel Ojanguren
Eugeni Domenech
A1
Journal Article
in
DIGESTIVE AND LIVER DISEASE
2017
Epstein-Barr virus-positive mucocutaneous ulcer in Crohn's disease : a condition to consider in immunosuppressed IBD patients
Alba Juan
Triana Lobatón Ortega
Gustavo Tapia
Miriam Manosa
Eduard Cabre
Eugeni Domenech
A1
Journal Article
in
DIGESTIVE AND LIVER DISEASE
2017
Long term outcome of ulcerative colitis patients responders to cyclosporine in the biological era
Guillermo Bastida
Lluisa Sargatal
Valle Garcia-Sanchez
Francisco Mesonero
Ana Mara Braitwaithe
Antonia Montserrat
Maria Dolores Martin Arranz
Beatriz Sicilia Aladren
David Olivares
Raquel Vicente
et al.
C3
Conference
2017
Long-term outcome of ulcerative colitis patients responders to cyclosporine in the biological era
G. Bastida
L. Sargalt
V. Garcia
F. Mesonero
A. M. Braithwaite
A. Montserrat
M. D. Martin
B. Sicilia
D. Olivares
R. Vicente
et al.
C3
Conference
2017
Long-term safety of in utero exposure to anti-tumor necrosis factor for the treatment of inflammatory bowel diseases : results from the multicenter European TEDDY study
M. Chaparro
A. Verreth
Triana Lobatón Ortega
M. Julsgaard
E. Savarino
F. Magro
I. Avni Biron
P. Lopez-Serrano
M. Casanova
M. Gompertz
et al.
C3
Conference
2017
Real-life infliximab trough levels among inflammatory bowel disease patients on maintenance therapy : should we redefine therapeutic range based on inflammatory load?
Triana Lobatón Ortega
F. Canete
A. Teniente
E. Cabre
M. Manosa
E. Martinez
E. Domenech
C3
Conference
2017
The availability of infliximab trough levels in IBD patients on maintenance therapy deeply impacts therapeutic decision-making
Triana Lobatón Ortega
F. Canete
A. Teniente
E. Cabre
M. Manosa
E. Martinez
E. Domenech
C3
Conference
2017
Therapeutic requirements in active ulcerative proctitis : a single-centre study
Margalida Calafat
Triana Lobatón Ortega
Miriam Manosa
Laura Marin
Noemi Caballero
Macarena Larrain
Eduard Cabre
Eugeni Domenech
A1
Journal Article
in
GASTROENTEROLOGIA Y HEPATOLOGIA
2017
2016
Bacterial intestinal superinfections in inflammatory bowel diseases beyond Clostridum difficile
Triana Lobatón Ortega
Eugeni Domenech
A1
Journal Article
in
INFLAMMATORY BOWEL DISEASES
2016
Predicting outcomes to optimize disease management in inflammatory bowel diseases
Joana Torres
Flavio Caprioli
Konstantinos H. Katsanos
Triana Lobatón Ortega
Dejan Micic
Marco Zeroncio
Gert Van Assche
James C. Lee
James O. Lindsay
David T. Rubin
et al.
A1
Journal Article
in
JOURNAL OF CROHNS & COLITIS
2016
Validation of the simplified Geboes score for ulcerative colitis
Aranzazu Jauregui-Amezaga
Yannick Das
Triana Lobatón Ortega
Bart Lemmens
Talat Bessissow
Marc Ferrante
Gert Van Assche
Raf Bisschops
Karel Geboes
Gert De Hertogh
et al.
C3
Conference
2016
2015
A simplified histological geboes score for ulcerative colitis
Aranzazu Jauregui-Amezaga
Gert De Hertogh
Talat Bessissow
Bart Lemmens
Triana Lobatón Ortega
Marc Ferrante
Raf Bisschops
Gert Van Assche
Severine Vermeire
Karel Geboes
C3
Conference
2015
Aeromonas species : an opportunistic enteropathogen in patients with inflammatory bowel diseases? A single center cohort study
Triana Lobatón Ortega
Ilse Hoffman
Severine Vermeire
Marc Ferrante
Jan Verhaegen
Gert Van Assche
A1
Journal Article
in
INFLAMMATORY BOWEL DISEASES
2015
An urgent referral strategy for symptomatic patients with suspected colorectal cancer based on a quantitative immunochemical faecal occult blood test
Lorena Rodriguez-Alonso
Francisco Rodriguez-Moranta
Alexandra Ruiz-Cerulla
Triana Lobatón Ortega
Claudia Arajol
Gemma Binefa
Victor Moreno
Jordi Guardiola
A1
Journal Article
in
DIGESTIVE AND LIVER DISEASE
2015
Efficacy and safety of anti-TNF therapy in elderly patients with inflammatory bowel disease
Triana Lobatón Ortega
M. Ferrante
P. Rutgeerts
V. Ballet
G. Van Assche
S. Vermeire
A1
Journal Article
in
ALIMENTARY PHARMACOLOGY & THERAPEUTICS
2015
High within-day variability of fecal calprotectin levels in patients with active ulcerative colitis : what is the best timing for stool sampling?
Margalida Calafat
Eduard Cabre
Miriam Manosa
Triana Lobatón Ortega
Laura Marin
Eugeni Domenech
A1
Journal Article
in
INFLAMMATORY BOWEL DISEASES
2015
The Modified Mayo Endoscopic Score (MMES) : a new index for the assessment of extension and severity of endoscopic activity in ulcerative colitis patients
Triana Lobatón Ortega
Talat Bessissow
Gert De Hertogh
Bart Lemmens
Chelsea Maedler
Gert Van Assche
Severine Vermeire
Raf Bisschops
Paul Rutgeerts
Alain Bitton
et al.
A1
Journal Article
in
JOURNAL OF CROHNS & COLITIS
2015
2014
Fecal level of calprotectin identifies histologic inflammation in patients with ulcerative colitis in clinical and endoscopic remission
Jordi Guardiola
Triana Lobatón Ortega
Lorena Rodriguez-Alonso
Alexandra Ruiz-Cerulla
Claudia Arajol
Carolina Loayza
Xavier Sanjuan
Elena Sanchez
Francisco Rodriguez-Moranta
A1
Journal Article
in
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY
2014
Long-term comparative efficacy of cyclosporine- or infliximab-based strategies for the management of steroid-refractory ulcerative colitis attacks
Juan E. Naves
Jordina Llao
Alexandra Ruiz-Cerulla
Cristina Romero
Miriam Manosa
Triana Lobatón Ortega
Eduard Cabre
Esther Garcia-Planella
Jordi Guardiola
Eugeni Domenech
A1
Journal Article
in
INFLAMMATORY BOWEL DISEASES
2014
Relationship between methylation and colonic inflammation in inflammatory bowel disease
Triana Lobatón Ortega
Daniel Azuara
Francisco Rodriguez-Moranta
Carolina Loayza
Xavier Sanjuan
Javier de Oca
Ana Fernandez-Robles
Jordi Guardiola
Gabriel Capella
A1
Journal Article
in
WORLD JOURNAL OF GASTROENTEROLOGY
2014
Review article : anti-adhesion therapies for inflammatory bowel disease
Triana Lobatón Ortega
S. Vermeire
G. Van Assche
P. Rutgeerts
A1
Journal Article
in
ALIMENTARY PHARMACOLOGY & THERAPEUTICS
2014
2013
A new rapid quantitative test for fecal calprotectin predicts endoscopic activity in ulcerative colitis
Triana Lobatón Ortega
Francisco Rodriguez-Moranta
Alicia Lopez
Elena Sanchez
Lorena Rodriguez-Alonso
Jordi Guardiola
A1
Journal Article
in
INFLAMMATORY BOWEL DISEASES
2013
Calprotectina fecal en el diagnóstico de enfermedades inflamatorias
Francisco Rodriguez-Moranta
Triana Lobatón Ortega
Lorena Rodriguez-Alonso
Jordi Guardiola
A1
Journal Article
in
GASTROENTEROLOGIA Y HEPATOLOGIA
2013
Characteristics and treatment of pyoderma gangrenosum in inflammatory bowel disease
F. Argueelles-Arias
L. Castro-Laria
Triana Lobatón Ortega
M. Aguas-Peris
M. Rojas-Feria
M. Barreiro-de Acosta
P. Soto-Escribano
M. Calvo-Moya
D. Ginard-Vicens
M. Chaparro-Sanchez
et al.
A1
Journal Article
in
DIGESTIVE DISEASES AND SCIENCES
2013
Comparison of the long-term outcome of two therapeutic strategies for the management of abdominal abscess complicating Crohn's disease : percutaneous drainage or immediate surgical treatment
Triana Lobatón Ortega
J. Guardiola
F. Rodriguez-Moranta
M. Millan-Scheiding
M. Penalva
J. De Oca
S. Biondo
A1
Journal Article
in
COLORECTAL DISEASE
2013
Contribution of the SPECT and SPECT/CT with radiolabeled leucocytes in the evaluation of the inflammatory bowel disease
O. Puig
J. Martin-Comin
A. Benitez Segura
A. Sabate-Llobera
P. Notta
Triana Lobatón Ortega
L. Camacho Berne
R. Puchal
J. Guardiola Capo
C3
Conference
2013
Novel methylation panel for the early detection of neoplasia in high-risk ulcerative colitis and Crohn's Colitis patients
Daniel Azuara
Francisco Rodriguez-Moranta
Javier de Oca
Xavier Sanjuan
Jordi Guardiola
Triana Lobatón Ortega
Alex Wang
Jaume Boadas
Marta Piqueras
David Monfort
et al.
A1
Journal Article
in
INFLAMMATORY BOWEL DISEASES
2013
2010
Antibiotic-resistant bacteria in spontaneous bacterial peritonitis : is it time to change?
J. Castellote
X. Ariza
A. Girbau
T. Broquetas
Triana Lobatón Ortega
S. Salord
R. Rota
X. Xiol
C3
Conference
2010
2009
Usefulness of reagent strips for checking cure in spontaneous bacterial peritonitis after short-course treatment
J. Castellote
A. Girbau
X. Ariza
S. Salord
X. Vazquez
Triana Lobatón Ortega
R. Rota
X. Xiol
A1
Journal Article
in
ALIMENTARY PHARMACOLOGY & THERAPEUTICS
2009